im assuming the positive efficacy results are from the ( April 2019 announcent.) 'we are in the process of implementing a Phase II type clinical trial in Australia, New Zealand and India.' which was a follow up trial from ( 17th Aug 2018 announcement).....'Completion of the Human Phase I/IIA trial in Australia with safety and efficacy results supporting commencement of a full efficacy study '....
